Evaluation of the neurofilament light chain as a biomarker in children with spinal muscular atrophy treated with nusinersen

This study aimed to evaluate the neurofilament light chain (NfL) as a biomarker for treatment responses in children with a broad spectrum of spinal muscular atrophy (SMA) under nusinersen treatment.
Source: Brain and Development - Category: Neurology Authors: Source Type: research